Browse Tag

UBS

Lam Research (LRCX) Stock After Hours on Dec. 23, 2025: UBS Lifts Target to $200—What to Know Before the Dec. 24 Market Open

Lam Research (LRCX) Stock After Hours on Dec. 23, 2025: UBS Lifts Target to $200—What to Know Before the Dec. 24 Market Open

Lam Research Corporation (NASDAQ: LRCX) ended Tuesday’s session near fresh highs and then ticked modestly higher in after-hours trading, as investors digested another round of bullish sell-side commentary and looked ahead to a holiday-shortened trading day on Wednesday. As of
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Wednesday, December 17, 2025, as fresh Wall Street commentary and a new round of target-price updates reframe the conversation around the medtech leader’s 2026 setup—especially in fast-growing cardiac categories
Legal & General (LGEN) share price today: UBS trims target to 260p as UK inflation cools — what investors are watching on 17 December 2025

Legal & General (LGEN) share price today: UBS trims target to 260p as UK inflation cools — what investors are watching on 17 December 2025

Legal & General Group Plc (LGEN) traded higher on 17 Dec 2025 as UBS cut its price target to 260p (neutral). Here’s the latest price action, the broker call, and key catalysts. Legal & General Group Plc (LSE: LGEN) is
Swiss Stock Market Week Ahead: SIX Swiss Exchange SMI Outlook After SNB Hold, UBS Rally and US Tariff Relief (Updated Dec 14, 2025)

Swiss Stock Market Week Ahead: SIX Swiss Exchange SMI Outlook After SNB Hold, UBS Rally and US Tariff Relief (Updated Dec 14, 2025)

As Switzerland heads into a new trading week, the SIX Swiss Exchange is entering mid-December with a familiar mix of defensive strength (pharma and consumer staples), policy-driven uncertainty (bank regulation and tariffs), and stock-specific catalysts that can still move the
14 December 2025
Swiss Stock Market Week Ahead: SNB at 0%, UBS Capital-Rules Compromise, Tariff Relief, and the Key Catalysts to Watch (Dec 15–19, 2025)

Swiss Stock Market Week Ahead: SNB at 0%, UBS Capital-Rules Compromise, Tariff Relief, and the Key Catalysts to Watch (Dec 15–19, 2025)

Zurich, Dec 13, 2025 — Swiss equities head into the new week with a familiar mix of “defensive resilience” and headline-driven volatility. The Swiss Market Index (SMI) spent the past several sessions grinding lower and struggling to hold early gains,
UBS Billionaire Ambitions Report 2025: Record $15.8 Trillion in Billionaires’ Wealth and a Historic Inheritance Wave

UBS Billionaire Ambitions Report 2025: Record $15.8 Trillion in Billionaires’ Wealth and a Historic Inheritance Wave

Published: December 8, 2025 The world has never had more billionaires—or more money concentrated in so few hands. According to UBS’s new Billionaire Ambitions Report 2025, global billionaire wealth has surged to an all‑time high of $15.8 trillion, spread across 2,919 individuals, up
1 2 3
Go toTop